Daniel Pfaff
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Advanced Glycation End Products research 4
-
- Peroxisome Proliferator-Activated Receptors 1
- Metabolism, Diabetes, and Cancer 1
- Co-authors
- Peter P. Nawroth (5 shared papers)Aurelio A. Teleman (6 shared papers)Thomas Fleming (3 shared papers)Alexandra Moraru (1 shared paper)Aubry K. Miller (1 shared paper)Janica L. Wiederstein (1 shared paper)Thomas Fleming (2 shared papers)Antonio Vidal‐Puig (1 shared paper)
- Journals
- Heliyon (1 paper)Cell Metabolism (1 paper)The Journal of Immunology (1 paper)Journal of Biological Chemistry (1 paper)Molecular Metabolism (1 paper)
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
Daniel Pfaff
7 papers receiving 344 citations
Peers
Comparison fields: 5 of 77
- Clinical Biochemistry 121
- Aging 7
- Endocrinology, Diabetes and Metabolism 51
- Physiology 70
- Neurology 23
Countries citing papers authored by Daniel Pfaff
This map shows the geographic impact of Daniel Pfaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Pfaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Pfaff more than expected).
Fields of papers citing papers by Daniel Pfaff
This network shows the impact of papers produced by Daniel Pfaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Pfaff. The network helps show where Daniel Pfaff may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Pfaff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 134 | |
| 2 | 2018 | 103 | |
| 3 | 2013 | 47 | |
| 4 | 2016 | 46 | |
| 5 | 2018 | 10 | |
| 6 | 2021 | 8 | |
| 7 | 2023 | 1 |
About Daniel Pfaff
Daniel Pfaff is a scholar working on Clinical Biochemistry, Molecular Biology, Endocrinology, Diabetes and Metabolism, Physiology and Neurology, having authored 7 papers that have together received 349 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), Natural Antidiabetic Agents Studies (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Cardiovascular and exercise physiology (1 paper), Immunotherapy and Immune Responses (1 paper), Biochemical effects in animals (1 paper), T-cell and B-cell Immunology (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Clinical Biochemistry (121 citations), Aging (7 citations), Endocrinology, Diabetes and Metabolism (51 citations), Physiology (70 citations) and Neurology (23 citations). Daniel Pfaff has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include Peter P. Nawroth, Aurelio A. Teleman, Thomas Fleming, Alexandra Moraru, Aubry K. Miller, Janica L. Wiederstein, Thomas Fleming, Antonio Vidal‐Puig, Sam Virtue and Deniz Senyilmaz. Their work appears in journals such as Heliyon, Cell Metabolism, The Journal of Immunology, Journal of Biological Chemistry and Molecular Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.